A detailed history of Bowling Portfolio Management LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Bowling Portfolio Management LLC holds 15,814 shares of GILD stock, worth $1.43 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares
15,814
Previous 16,560 4.5%
Holding current value
$1.43 Million
Previous $1.02 Million 4.69%
% of portfolio
0.27%
Previous 0.26%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 04, 2022

SELL
$59.54 - $68.01 $44,416 - $50,735
-746 Reduced 4.5%
15,814 $976,000
Q2 2022

Jul 21, 2022

BUY
$57.72 - $65.01 $955,843 - $1.08 Million
16,560 New
16,560 $1.02 Million
Q1 2018

Apr 25, 2018

SELL
$72.84 - $88.8 $1.59 Million - $1.94 Million
-21,869 Closed
0 $0
Q4 2017

Jan 22, 2018

SELL
$71.15 - $83.52 $20,348 - $23,886
-286 Reduced 1.29%
21,869 $1.57 Million
Q3 2017

Oct 16, 2017

BUY
$72.11 - $85.47 $1.6 Million - $1.89 Million
22,155
22,155 $1.8 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $113B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Bowling Portfolio Management LLC Portfolio

Follow Bowling Portfolio Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bowling Portfolio Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bowling Portfolio Management LLC with notifications on news.